Cellular Goods PLC Launch of inaugural products & ecommerce platform (0878U)
01 December 2021 - 5:59PM
UK Regulatory
TIDMCBX
RNS Number : 0878U
Cellular Goods PLC
01 December 2021
The information contained within this announcement is deemed by
the Company to constitute inside information stipulated under the
Market Abuse Regulation (EU) No. 596/2014, as retained as part of
the law of England and Wales. Upon the publication of this
announcement via the Regulatory Information Service, this inside
information is now considered to be in the public domain.
Press release
1 December 2021
Cellular Goods PLC
("Cellular Goods" or "the Company")
Launch of inaugural product range and ecommerce platform
Cellular Goods (LSE: CBX), a UK-based provider of premium
consumer products formulated with lab-made cannabinoids, is pleased
to announce the launch today of its inaugural product ranges and
ecommerce platform, found at cellulargoods.co.
The launch comprises two product ranges and comes just nine
months after the start-up of the Company's commercial operations
following its flotation on the London Stock Exchange.
The inaugural range comprises the UK's first premium CBG
(cannabigerol) skincare offering including a serum, a face-oil and
an after-shaving moisturiser. The products contain ultra-pure,
biosynthetic CBG, which has demonstrated anti-inflammatory,
anti-oxidant and anti-bacterial properties. All three products have
been through an extensive testing process and are fully validated
for marketing and labelling as suitable for sensitive skin,
dermatologically tested and dermatologist approved.
The second range is a clinically validated CBD (cannabidiol)
ingestibles range. This range complies with novel food regulations
in both the UK and the EU and is certified under Good Manufacturing
Practice (GMP) standards. The ingestibles range comprises a
tincture, a spray and capsules, covering the most popular methods
of consumption. These have been extensively tested to ensure
safety, stability and quality. Both product ranges do not require
the cultivation of the cannabis sativa plant, and contain 0% THC,
the psychoactive component of cannabis sativa.
In addition, the Company's new ecommerce platform has gone live,
enabling customers in the UK to place online purchase orders for
five of the six products as of today. The skincare serum will go on
sale from February 2022 due to supply constraints at the Company's
manufacturing partner until early in the new year.
Alexis Abraham, Chief Executive of Cellular Goods, commented:
"Today is a major milestone for the Company with the launch of the
UK's first CBG skincare products on a best-in-class ecommerce
platform. Leading with CBG sets us apart from the competition, and
to also be able to offer consumers CBD ingestibles at the same time
delivers on our vision to become the first true cannabinoid
company. We have taken less than a year from a standing start to
put Cellular Goods at the forefront of the cannabinoid and wellness
industries, and as of today, we have started a new chapter in our
growth by entering a revenue-generating phase. Consumers are now
familiar with CBD, and we believe there is a substantial and
growing demand for a more innovative and premium brand offering
clean, green, and compliant products and look forward to delivering
on our potential".
For further information please contact:
Cellular Goods
Alexis Abraham
Chief Executive +44 207 031 6871
Neil Thapar
Investor Relations +44 787 645 5323
-------------------
Tennyson Securities
-------------------
Corporate Broker
Peter Krens +44 207 186 9030
-------------------
Novum Securities
-------------------
Corporate Broker
Colin Rowbury
Jon Belliss +44 207 399 9427
-------------------
Tancredi Intelligent Communication
-------------------
Media Relations
Helen Humphrey
Edward Daly +44 744 922 6720
Fabio Galloni Roversi Monaco +44 786 143 0057
Charlie Hobbs +44 788 867 2701
Salamander Davoudi +44 789 755 7112
cellulargoods@tancredigroup.com +44 795 754 9906
-------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDDZMFMKGRGMZM
(END) Dow Jones Newswires
December 01, 2021 01:59 ET (06:59 GMT)
Cellular Goods (LSE:CBX)
Historical Stock Chart
From Apr 2024 to May 2024
Cellular Goods (LSE:CBX)
Historical Stock Chart
From May 2023 to May 2024